Co-creation and iterative needs assessment with patients and healthcare providers in an International phase II TILs therapy trial (PRAGMATIL)


Por: Cacilhas, P, Malagrida, R, Gillanders, E, Kuld-Nielsen, A, Everhard, S, Monras, M, Alberú, XV, Le Moal, F, Garralda, E, Aguiar, VG, García-Lema, J, Zuazua-Schücker, E, Vaz-Luis, IV, Vives-Adrián, L and Franzoi, MA

Publicada: 1 sep 2025 Ahead of Print: 1 sep 2025
Resumen:


Filiaciones:
Cacilhas, P:
 Inst Gustave Roussy, Canc Survivorship Grp, INSERM 981, Villejuif, France

:
 Fdn IrsiCaixa, IrsiCaixa, Badalona, Spain

Gillanders, E:
 Inst Gustave Roussy, Canc Survivorship Grp, INSERM 981, Villejuif, France

Kuld-Nielsen, A:
 Herlev Hosp, Natl Ctr Canc Immune Therapy CCIT DK, Dept Oncol, Herlev, Denmark

Everhard, S:
 Unicancer, Data & Partnerships Dept, Paris, France

Monras, M:
 Vall dHebron Inst Oncol VHIO, Vall dHebron Inst Oncol, Barcelona, Spain

Alberú, XV:
 Vall dHebron Inst Oncol VHIO, Vall dHebron Inst Oncol, Barcelona, Spain

Le Moal, F:
 Seintinelles, Paris, France

Garralda, E:
 Vall dHebron Univ Hosp, Vall dHebron Inst Oncol VHIO, Dept Med Oncol, Barcelona, Spain

Aguiar, VG:
 Vall dHebron Univ Hosp, Early Clin Drug Dev Grp, Barcelona, Spain

García-Lema, J:
 La Caixa Fdn, Barcelona, Spain

Zuazua-Schücker, E:
 La Caixa Fdn, Barcelona, Spain

Vaz-Luis, IV:
 Inst Gustave Roussy, Dept Med Oncol, Villejuif, France

Vives-Adrián, L:
 Fdn IrsiCaixa, IrsiCaixa, Badalona, Spain

Franzoi, MA:
 Inst Gustave Roussy, Canc Survivorship Grp, INSERM 981, Villejuif, France
ISSN: 09237534





Annals of Oncology
Editorial
Oxford University Press, RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS, Reino Unido
Tipo de documento: Meeting Abstract
Volumen: 36 Número:
Páginas:
WOS Id: 001632146900058
imagen Bronze

MÉTRICAS